A-1210477

A-1210477

Biochem/physiol Actions

A-1210477 is a BH3 mimetic that targets MCL-1 with high affinity (Ki = 0.43 nM) and selectivity (Ki >0.66 µM for BCL-2, BCL-XL, BCL-W, and A1), exhibiting little to no activity toward panels of 80 kinases (IC50 >8.5 µM) and 21 GPCRs (IC50 & EC50 >10 µM). A-1210477 selectively inhibits the survival of MCL-1-dependent (IC50 ~4 µM/multiple myeloma H929, 5.3 µM/NSCLC H2110, 7.2 µM/NSCLC H23), but not BCL-2-dependent RS4;11, cultures via apoptosis induction and potentiates BCL-2/BCL-XL inhibitor ABT-263 (Navitoclax) killing in a variety of cancer cell cultures where ABT-263 alone is ineffective. A-1210477 is also shown to cause cellular MCL-1 upregulation, most likely due to blocking MCL-1 interaction with BH3-only proteins such as NOXA and MULE known to mediate MCL-1 ubiquitylation for proteasomal degradation.

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level Manufacturer Storage Temp. Solubility Form Assay Price Quantity
3575572 A-1210477 white to beige 100 SIGMA-ALDRICH −20°C
£490.29 (exc VAT) per 25MG
-
+
3575573 A-1210477 white to beige 100 SIGMA-ALDRICH −20°C
£121.32 (exc VAT) per 5MG
-
+